Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17236223 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies
Condition: Oral Mucositis
Interventions: Drug: rhEGF + povidone iodine, chlorhexidine, & nystatin;   Drug: Placebo + povidone iodine, chlorhexidine, & nystatin

Indicates status has not been verified in more than two years